期刊文献+

左氧氟沙星人体内外相关性研究 被引量:2

Studies on Correlation between Dissolution in Vitro and Absorption in Vivo of Levofloxacin Tablets
下载PDF
导出
摘要 目的研究两种左氧氟沙星片剂的体内-体外相关性。方法用不同转速测定两种左氧氟沙星片剂(分别由A,B两厂生产)的体外溶出度。采用反相高效液相色谱法测定18名健康志愿受试者单剂量口服两种左氧氟沙星片后的血药浓度,用3P97软件计算药动学参数,Wagner-Nelson法计算药物的体内吸收百分数,并分析体内外相关性。结果两厂生产的左氧氟沙星片剂在体内生物等效。以50,75,100r.min-1进行左氧氟沙星片体外溶出结果均符合《中国药典》2005年版要求。其中,以50r.min-1转速所作的体外溶出结果与体内生物利用度相关,回归方程为A:fa=2.0176ft+0.7279,r=0.957(P<0.05)。B:fa=1.8929ft+0.7749,r=0.955(P<0.05)。结论体外溶出试验与体内生物利用度有良好的体内外相关性,可用体外溶出度来控制制剂质量。 OBJECTIVE To investigate the relationship between dissolution in vitro and absorption in vivo of levofloxacin tablets from two pharmaceutical coorperations(A and B). METHODS The dissolution of levofloxacin was determined in vitro according to Chinese pharmacopoeia (2005ed Part Ⅱ) with different rotation speed. Levofloxacin concentration in plasma was determined by RP-HPLC after a single dose of oral levofloxacin tablets given to 18 healthy male volunteers. Their pharmacokinetic parameters were obtained by 3P97 program,and the absorption percentage was calculated according to Wangner-Nelson formula. RESULTS The two preparations were bioequivalent. The dissolution parameters of levofloxacin tablets with different rotation speed (50,75 and 100 r·min^-1 ) all met the requirement of Chinese pharmacopoeia. The linear regressive equation was established between the absorption percentage in vivofa and accumulate release percentage in vitro (50 r·min^-1 ) ft of levofloxacin tablets as A :fa = 2. 017 6ft + 0. 727 9, r = 0. 957 ( P 〈 0. 05 ) ; B .fa = 1. 892 9ft + 0. 774 9, r = 0. 955 ( P 〈 0. 05 ). CONCLUSION There was a significant relationship between absorption in vivo and in vitro.
出处 《中国药学杂志》 CAS CSCD 北大核心 2007年第15期1178-1181,共4页 Chinese Pharmaceutical Journal
关键词 左氧氟沙星 高效液相色谱法 生物利用度 溶出度 体内外相关性 levofloxacin HPLC bioavailability dissolution in vivo and in vitro correlation
  • 相关文献

参考文献6

二级参考文献14

  • 1唐建国.氟喹诺酮药物左氟沙星[J].国外医药(抗生素分册),1996,17(5):380-387. 被引量:43
  • 2陈新谦 金有豫.新编药物学(第14版)[M].北京:人民卫生出版社,1997.487.
  • 3Chow AT, Fowler F, Williams RR, et al. Safety and pharmacokinetics of multiple 750 mg dose of Intravenous levofloxacin in healthy volunteers[J]. Antimicrob Agents Chemother ,2001,45(7) :2122.
  • 4Tumidge J.Pharmackinitics and pharmacodynamics of fluoroquinolones [J]. Drugs,1999,58(Suppl 2):29.
  • 5Lister PD,Sanders CC. Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae[J]. J Antimicrob Chemother,1999,43:79.
  • 6Lacey MK, Lu W, Xu X, et al. Pharmacodynamic compareison of levofloxacin ciprofloxacin and amipicillin against streptococcus pneumoniae in vivo and in vitro model of infection [ J ]. Antimicrob Agents Chemother, 1997,43: 672.
  • 7Nightinale CH, Grant EM, Quintilliani R. Pharmacokinetics and pharmacodynamics of levofloxacin[J]. Chemother ,2000,46(Suppl 1 ):6.
  • 8Zinner SH, Simmons K, Gilbert B.Comparative activities of eiprofloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro dynamic model [J]. Antimicrob Agents Chemother,2000,44:773.
  • 9Pickerill KE, Pelladino JA, Schentag JJ.Comparison of fluoroquinolones based on pharmacokinetic/pharmacodynamic parameters [J]. Pharmacother , 2000 , 20 : 417 .
  • 10司凯英,段京莉,严宝霞.生物法和HPLC测定左氧氟沙星血药浓度的比较[J].中国药学杂志,1999,34(1):43-45. 被引量:9

共引文献17

同被引文献30

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部